Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company") ...
Backed by Apollo Health Ventures, Nula aims to transform treatment of metabolic dysfunctionARPA-H award brings total funding ...
Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...
Thermoreversible revyve transforms deep tunneling wound care, delivering 90% wound volume reductionrevyve rapidly normalizes ...
UEL believes more lab space could mean more innovation for Minnesota. Plus: The coffee brand that fights inflammation.
A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pandemic, reducing ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...
CUMBERLAND – Advanced Placement Biology students at Cumberland High School conducted a hands-on lab experiment using ...
Workers in America face confusion due to conflicting directions from multiple supervisors. This role ambiguity, often seen ...
What started as one pioneering Boston running brand's unique approach to marathon weekend has transformed into a crowded ...
Shares of Veradermics, a developer of a pill for hair loss, have shot up since its February IPO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results